329217-66-5

Basic information

• Product Name: Benzaldehyde, 4-methoxy-3-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-
• CAS NO: 329217-66-5
• Molecular Formula: C23H28O2
• Molecular Weight: 336.474
• Mol File: 329217-66-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 4-methoxy-3-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 4-methoxy-3-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-(329217-66-5)
• EPA Substance Registry System: Benzaldehyde, 4-methoxy-3-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-(329217-66-5)

Safety Data

• Hazardous Substances Data: 329217-66-5(Hazardous Substances Data)

Upstream product

• 34841-06-0 3-bromo-4-methoxybenzylaldehyde 
• 169126-64-1 (3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-boronic acid 

Downstream Products

• 329218-05-5 4-hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzaldehyde 

Relevant articles and documents

Heterocyclic derivatives for the treatment of diabetes and other diseases

The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.

Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia

The present invention relates to compounds of Formula (I) which may be useful in the treatment of diseases, such as, metabolic disorders, dyslipidemia and/or hyperchloesterolemia: 1